chr13-113106101-G-A

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_019616.4(F7):​c.64+196G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.593 in 149,540 control chromosomes in the GnomAD database, including 26,587 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.59 ( 26587 hom., cov: 23)

Consequence

F7
NM_019616.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.789

Publications

4 publications found
Variant links:
Genes affected
F7 (HGNC:3544): (coagulation factor VII) This gene encodes coagulation factor VII which is a vitamin K-dependent factor essential for hemostasis. This factor circulates in the blood in a zymogen form, and is converted to an active form by either factor IXa, factor Xa, factor XIIa, or thrombin by minor proteolysis. Upon activation of the factor VII, a heavy chain containing a catalytic domain and a light chain containing 2 EGF-like domains are generated, and two chains are held together by a disulfide bond. In the presence of factor III and calcium ions, the activated factor then further activates the coagulation cascade by converting factor IX to factor IXa and/or factor X to factor Xa. Defects in this gene can cause coagulopathy. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing to generate mature polypeptides. [provided by RefSeq, Aug 2015]
F7 Gene-Disease associations (from GenCC):
  • congenital factor VII deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Orphanet, Ambry Genetics
  • factor VII deficiency
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 13-113106101-G-A is Benign according to our data. Variant chr13-113106101-G-A is described in ClinVar as [Benign]. Clinvar id is 1277836.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.638 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
F7NM_019616.4 linkc.64+196G>A intron_variant Intron 1 of 7 ENST00000346342.8 NP_062562.1 P08709-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
F7ENST00000346342.8 linkc.64+196G>A intron_variant Intron 1 of 7 1 NM_019616.4 ENSP00000329546.4 P08709-2
F7ENST00000375581.3 linkc.64+196G>A intron_variant Intron 1 of 8 1 ENSP00000364731.3 P08709-1
F7ENST00000541084.5 linkc.64+196G>A intron_variant Intron 1 of 5 2 ENSP00000442051.2 F5H8B0
F7ENST00000444337.1 linkn.64+196G>A intron_variant Intron 1 of 4 5 ENSP00000387669.1 E9PH36

Frequencies

GnomAD3 genomes
AF:
0.593
AC:
88643
AN:
149420
Hom.:
26573
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.507
Gnomad AMI
AF:
0.569
Gnomad AMR
AF:
0.591
Gnomad ASJ
AF:
0.732
Gnomad EAS
AF:
0.507
Gnomad SAS
AF:
0.583
Gnomad FIN
AF:
0.600
Gnomad MID
AF:
0.619
Gnomad NFE
AF:
0.644
Gnomad OTH
AF:
0.612
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.593
AC:
88689
AN:
149540
Hom.:
26587
Cov.:
23
AF XY:
0.590
AC XY:
42997
AN XY:
72834
show subpopulations
African (AFR)
AF:
0.507
AC:
20525
AN:
40490
American (AMR)
AF:
0.590
AC:
8895
AN:
15070
Ashkenazi Jewish (ASJ)
AF:
0.732
AC:
2536
AN:
3464
East Asian (EAS)
AF:
0.508
AC:
2446
AN:
4816
South Asian (SAS)
AF:
0.583
AC:
2709
AN:
4648
European-Finnish (FIN)
AF:
0.600
AC:
6162
AN:
10274
Middle Eastern (MID)
AF:
0.613
AC:
179
AN:
292
European-Non Finnish (NFE)
AF:
0.644
AC:
43455
AN:
67528
Other (OTH)
AF:
0.617
AC:
1273
AN:
2064
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.522
Heterozygous variant carriers
0
1704
3408
5112
6816
8520
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
748
1496
2244
2992
3740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.611
Hom.:
6530
Bravo
AF:
0.584
Asia WGS
AF:
0.534
AC:
1860
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jun 18, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.94
DANN
Benign
0.44
PhyloP100
-0.79
PromoterAI
-0.0017
Neutral
RBP_binding_hub_radar
0.85
RBP_regulation_power_radar
2.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2774030; hg19: chr13-113760415; API